Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 23, 2010, Pages 2150-2154

  Sparidans, Rolf W ^a   van Velsen, Sara G A ^b   de Roos, Marlise P ^a   Schellens, Jan H M ^a,c   Bruijnzeel Koomen, Carla A F M ^b   Beijnen, Jos H ^a,c,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Atopic dermatitis; Clobetasol propionate; Clobetasone butyrate; Human serum; LC MS MS; Topical corticosteroid

Indexed keywords

ANALYTES; ATOPIC DERMATITIS; BIOANALYTICAL ASSAYS; ELECTROSPRAY INTERFACES; HUMAN SERUM; INTERNAL STANDARDS; ISOCRATIC ELUTION; LC-MS/MS; LOWER LIMIT OF QUANTIFICATIONS; MOBILE PHASE; OCTADECYL SILICA; QUANTITATIVE ASSAY; SELECTIVE REACTION MONITORING; TANDEM MASS SPECTROMETRIC; TRIPLE-QUADRUPOLE MASS SPECTROMETER; WATER-METHANOL;

BODY FLUIDS; ELECTROSPRAY IONIZATION; ETHERS; HEXANE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; METHANOL; ORGANIC ACIDS; SILICA;

DERMATITIS;

CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; FORMIC ACID; METHANOL; WATER; ANTIINFLAMMATORY AGENT; CLOBETASOL;

ACCURACY; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; DRUG BLOOD LEVEL; ELECTROSPRAY; FEMALE; HUMAN; IONIZATION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; BLOOD; CALIBRATION; CHEMISTRY; CLINICAL TRIAL; DRUG STABILITY; LIMIT OF DETECTION; PROCEDURES; REPRODUCIBILITY; YOUNG ADULT;

AGED; ANTI-INFLAMMATORY AGENTS; CALIBRATION; CHROMATOGRAPHY, LIQUID; CLOBETASOL; DERMATITIS, ATOPIC; DRUG STABILITY; FEMALE; HUMANS; LIMIT OF DETECTION; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 77955053468     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.06.011     Document Type: Article

References (12)

1. Allenby C.F., Main R.A., Marsden R.A., Sparkes C.G. Br. Med. J. 1975, 4:619.
2. Gip L., Hamfelt A. Cutis 1984, 33:215.
3. Hehir M., Du Vivier A., Eilon L., Danie M.J., Shenoy E.V. Clin. Exp. Dermatol. 1983, 8:143.
4. Pariser D. Am. J. Ther. 2009, 16:264.
5. Center for Drug Evaluation and Research of the U.S. Department of Health and Human Services Food and Drug Administration, 2001. (accessed: August 3, 2009). http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm064964.htm.
6. European Medicines Agency, 2009. (accessed: June 1, 2010). http://www.ema.europa.eu/pdfs/human/ewp/19221709en.pdf.
7. Luo Y., Uboh C.E., Soma L.R., Guan F.Y., Rudy J.A., Tsang D.S. Rapid Commun. Mass Spectrom. 2005, 19:1245.
8. dos Santos Pereira A., Oliveira L.S., Mendes G.D., Gabbai J.J., De Nucci G. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 828:27.
9. Zou J.J., Dai L., Ding L., Xiao D.W., Bin Z.Y., Fan H.W., Liu L., Wang G.J. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2008, 873:159.
10. Rauh M. Mol. Cell Endocrinol. 2009, 301:272.
11. Cui X., Shao B., Zhao R., Yang Y., Hu J., Tu X. Rapid Commun. Mass Spectrom. 2006, 20:2355.
12. Antignac J.-P., Monteau F., Negriolli J., Andre F., Le Bizec B. Chromatographia 2003, 59:S13.